The effect of 5 mg pindolol on stress-induced disturbances of performance were assessed in 30 professional musicians. An overall inverse relationship was found between anxiety and musical performance. Reduction in anxiety by administration of pindolol was associated with a subjective improvement in performance. A stressrelated tachycardia and increase in systolic blood pressure were attenuated. Pindolol had no effect on peak flow measurements.
Introduction
The exact relationship between anxiety and the performance of tasks requiring skill, coordination and judgment is complex. Thus it is commonly held that some apprehension is necessary for them to be performed reasonably well. However, as apprehension and anxiety increase, although performance itself initially improves, eventually there comes a point when not only does no further improvement take place, but deterioration occurs. Once this stage is reached, deterioration can be both rapid and catastrophic.
Attempts to improve the performance of intricate tasks adversely affected in such a manner by the use of beta-adrenoceptor blocking drugs have been made on a number of occasions in the past with some success (Krishnan 1976 , James et al. 1977 , Brantigan et al. 1979 , 1982 . In such double-blind clinical trials, when crossover techniques have been employed, the difference between the active medication and placebo always appears to be much greater on the first day when apprehension is presumably greater, than on the second day of the study when apprehension is probably less. The aim of the present investigation was to assess the effect of the beta-blocking drug pindolol on the adverse influences of excessive anxiety on performance. Musical performance was again chosen as a suitable model for study and a non-crossover design was employed.
Professional musicians were asked to perform before an invited audience on two occasions. On the first occasion half were given pindolol 5 mg and half placebo in a conventional double-blind fashion. All were given placebo on the second occasion to ensure the comparability of the groups. Participants and assessors were encouraged in the erroneous belief that a crossover design was to be employed.
Methods
Thirty professional musicians participated in the investigation; most were orchestral members but there were, in addition, a number of pianists. Each gave two recitals lasting approximately 15 minutes before an invited audience. The recitals were held at least a week but less than a fortnight apart. The performances were given in combinations of up to four individuals. The programme was kept constant for each group on both occasions. Some ten concerts were arranged in all. Every performer was asked to take either 5 mg pindolol or matching placebo I! hours prior to playing. Half the subjects took pindolol on the first occasion (Group A players) and half took placebo (Group B). This was randomized in the conventional way and was doubly blind. On the second occasion all players (Groups A and B) took placebo. Players were always blind as to whether they were taking drug or placebo. The music assessor was blind to therapy and to the scientific design of the study. Coffee and alcohol were forbidden on the days of the concerts. Clinical measurements Standing heart rate and standing blood pressure were taken by a trained but 'blinded' observer just before the subjects went 'on stage'. The musicians' anxiety was graded by asking them how they felt: extremely calm scored I, slightly apprehensive 2, apprehensive 3, very apprehensive 4 and panic-stricken 5.
After each performance three peak flow assessments of ventilatory function were made. The best of three measurements was recorded by the observer.
Musical assessments' of performance Subjective assessment: Each performer was asked to rate his own performance as I terrible, 2 bad, 3 mediocre, 4 good, 5 very good. They were also asked to grade their performance as I much better than expected, 2 better than expected, 3 same as expected, 4 worse than expected and 5 much worse than expected (comparative rating).
Objective assessment: Each performance was scored between 0 to 10 by an experienced professional musician. There were 19 string players, 8 woodwind players and 3 pianists. They were stratified in the randomization process to ensure comparability of groups, numbering 9, 4, 2 in the beta-blocker (A) group and 10, 4, I in the placebo (B) group. In addition to analysis of the complete group, it was decided to analyse the results from better players separately from those of weaker players. The placing of players into either the strong-or weaker-player subgroups was done by the music assessor since the capabilities of the volunteers were known to her.
Results
The results are given in Table I . Pulse rate and systolic blood pressure were significantly lower in those receiving pindolol compared with placebo. There was no difference between the groups in diastolic blood pressure or in peak flow measurements. Pindolol decreased anxiety and caused a subjective improvement in musical performance. This reached the 5% significance level for comparative rating but not for the absolute rating scale. There was no objective improvement in the overall assessment, but improvement was noted in the better players' scores. Whilst performance on the second occasion did not affect the pulse rate increase, the anxiety score was usually lower and performance was better than on the first occasion. In addition there was an overall inverse relationship between anxiety and performance in players on the second occasion when all were on placebo ( Figure 1 ).
Discussion
A 5 mg dose of pindolol is able to ameliorate the adverse effects of stress on musical performance. In this study the improvement noted was mainly subjective. The objective assessment failed to demonstrate an overall improvement, although surprisingly improvement was noted in the subgroup of better players. The objective assessment scores showed a large amount of variation, which may have disguised a drug effect. In retrospect, it would perhaps have been better to have limited the number of those performing at the same time to one or possibly two players. Nevertheless, the results for pindolol are essentially the same as those for oxprenolol (James et al. 1977 ) and propranolol (Brantigan et al. 1979 , 1982 . In the present study the results from the second performance confirmed that when the subjects were less nervous the performance improved. The fact that on the second occasion the results of both groups, i.e. those given beta-blocker on the first occasion (Group A) and those given placebo on the first occasion (Group B), were essentially the same suggests that the difference in score on the first occasion could not be due to some strange quirk of randomization.
The results of the present study and those cited above confirm the beneficial effects of beta-blocking drugs on musical performance. The question of whether they should be used in such circumstances still remains to be answered. The present authors agree with the views of Brantigan et al. (1982) on this matter: for performers who are so incapacitated by anxiety that their livelihood is in jeopardy, beta-blocking drugs should be used. Interestingly enough it is often not the young performer who suffers in this way; the syndrome of stage-fright frequently suddenly affects the well-established musician of many years' standing. Such players can benefit from retraining programmes in which beta-blocking drugs play an integral part. An argument can also be advanced for their use in isolated episodes of severe acute stress, such as during a major recital or audition.
